52875-2 |
Cells.CD1a/Cells |
NFr |
CSF |
Pt |
Qn |
|
|
ACTIVE |
CD1a cells/cells in Cerebral spinal fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52875-2 |
|
|
|
|
Observation |
|
|
|
0 |
CD1a Cells NFr CSF |
|
|
|
N |
|
CD1a Cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; HTA1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R4; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52876-0 |
Cells.CD1a/Cells |
NFr |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
CD1a cells/cells in Tissue |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52876-0 |
|
|
|
|
Observation |
|
|
|
0 |
CD1a Cells NFr Tiss |
|
|
|
N |
|
CD1a Cells; Cell; CELL MARKERS; Cellularity; HTA1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R4; Random; Tissue; Tissue, unspecified |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52877-8 |
Cells.cytoplasmic CD22/Cells |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD22 cells/cells in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52877-8 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD22 Cells NFr Bld |
|
|
|
N |
|
B3; B-3; BL-CAM; Blood; Cell; CELL MARKERS; Cellularity; CyCD22; cyCD22 Cells; Cytopl; Cytoplas; Leu14; Leu-14; Lyb8; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; To-15; WB; Whole blood |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52878-6 |
Cells.cytoplasmic CD22/Cells |
NFr |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD22 cells/cells in Body fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52878-6 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD22 Cells NFr Fld |
|
|
|
N |
|
B/F; B3; B-3; BF; BL-CAM; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; CyCD22; cyCD22 Cells; Cytopl; Cytoplas; Fl; Fld; FLU; Fluid; Leu14; Leu-14; Lyb8; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; To-15 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52879-4 |
Cells.cytoplasmic CD22/Cells |
NFr |
Bone mar |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD22 cells/cells in Bone marrow |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52879-4 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD22 Cells NFr Mar |
|
|
|
N |
|
B3; B-3; BL-CAM; BM; BON; Bone marrow; Cell; CELL MARKERS; Cellularity; CyCD22; cyCD22 Cells; Cytopl; Cytoplas; Leu14; Leu-14; Lyb8; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; To-15 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
5288-6 |
Rabies virus Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Rabies virus Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5288-6 |
|
|
|
|
Both |
|
|
|
0 |
RABV Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Rabies; RABV; Random; Serum; SR |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
52880-2 |
Cells.cytoplasmic CD22/Cells |
NFr |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD22 cells/cells in Cerebral spinal fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52880-2 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD22 Cells NFr CSF |
|
|
|
N |
|
B3; B-3; BL-CAM; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; CyCD22; cyCD22 Cells; Cytopl; Cytoplas; Leu14; Leu-14; Lyb8; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; To-15 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52881-0 |
Cells.cytoplasmic CD22/Cells |
NFr |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD22 cells/cells in Tissue |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52881-0 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD22 Cells NFr Tiss |
|
|
|
N |
|
B3; B-3; BL-CAM; Cell; CELL MARKERS; Cellularity; CyCD22; cyCD22 Cells; Cytopl; Cytoplas; Leu14; Leu-14; Lyb8; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; To-15 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52882-8 |
Cells.cytoplasmic CD3/Cells |
NFr |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD3 cells/cells in Body fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52882-8 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD3 Cells NFr Fld |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; cyCD3; cyCD3 Cells; Cytopl; Cytoplas; Fl; Fld; FLU; Fluid; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52883-6 |
Cells.cytoplasmic CD3/Cells |
NFr |
Bone mar |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD3 cells/cells in Bone marrow |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52883-6 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD3 Cells NFr Mar |
|
|
|
N |
|
BM; BON; Bone marrow; Cell; CELL MARKERS; Cellularity; cyCD3; cyCD3 Cells; Cytopl; Cytoplas; Leu4; Leu-4; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52884-4 |
Cells.cytoplasmic CD3/Cells |
NFr |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD3 cells/cells in Cerebral spinal fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52884-4 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD3 Cells NFr CSF |
|
|
|
N |
|
Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; cyCD3; cyCD3 Cells; Cytopl; Cytoplas; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T3 |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52885-1 |
Cells.cytoplasmic CD3/Cells |
NFr |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Cytoplasmic CD3 cells/cells in Tissue |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
52885-1 |
|
|
|
|
Observation |
|
|
|
0 |
cyCD3 Cells NFr Tiss |
|
|
|
N |
|
Cell; CELL MARKERS; Cellularity; cyCD3; cyCD3 Cells; Cytopl; Cytoplas; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; Tissue; Tissue, unspecified |
2.79 |
2.24 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
52886-9 |
Tellurium |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Tellurium [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/d |
|
|
|
|
|
|
DRUG/TOX |
|
52886-9 |
|
|
|
|
Both |
|
|
|
0 |
Tellurium 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; TE; UA; UR; Urn |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
52887-7 |
Bismuth |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Bismuth [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
NMOL/D |
|
|
|
|
|
|
DRUG/TOX |
|
52887-7 |
|
|
|
|
Both |
|
|
|
0 |
Bismuth 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; BI; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
52888-5 |
Silicon |
SCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Silicon [Moles/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
52888-5 |
|
|
|
|
Both |
|
|
|
0 |
Silicon Tiss-sCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; SI; Substance content; Tissue; Tissue, unspecified |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
52889-3 |
Selenium |
SCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Selenium [Moles/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
52889-3 |
|
|
|
|
Both |
|
|
|
0 |
Selenium Tiss-sCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; Substance content; Tissue; Tissue, unspecified |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
5289-4 |
Reagin Ab |
ACnc |
CSF |
Pt |
Qn |
VDRL |
|
ACTIVE |
Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5289-4 |
|
VDRL |
|
|
Both |
|
|
|
0 |
VDRL CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Microscopic flocculation; Neuro; Neurology; Neurosyphilis; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; Treponema; Venereal Disease Research Laboratory |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
52890-1 |
Lead |
SCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Lead [Moles/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
52890-1 |
|
|
|
|
Both |
|
|
|
0 |
Lead Tiss-sCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Tissue; Tissue, unspecified |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
52891-9 |
Chromium |
SCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Chromium [Moles/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
52891-9 |
|
|
|
|
Both |
|
|
|
0 |
Cr Tiss-sCnt |
|
|
|
N |
|
c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Tissue; Tissue, unspecified |
2.75 |
2.24 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
52892-7 |
Aluminum |
SCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Aluminum [Moles/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
52892-7 |
|
|
|
|
Both |
|
|
|
0 |
Aluminum Tiss-sCnt |
|
|
|
N |
|
AL; Aluminium; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Tissue; Tissue, unspecified |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
52893-5 |
Vanadium |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Vanadium [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
52893-5 |
|
|
|
|
Both |
|
|
|
0 |
Vanadium SerPl-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; V |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
52894-3 |
Titanium |
SCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Titanium [Moles/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
52894-3 |
|
|
|
|
Both |
|
|
|
0 |
Titanium RBC-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; TI |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
52895-0 |
Tellurium |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Tellurium [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
52895-0 |
|
|
|
|
Both |
|
|
|
0 |
Tellurium Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TE; UA; UR; Urn |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
52896-8 |
Silver |
SCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Silver [Moles/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
52896-8 |
|
|
|
|
Both |
|
|
|
0 |
Silver RBC-sCnc |
|
|
|
N |
|
Ag; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Silv; Substance concentration |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
52897-6 |
Platinum |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Platinum [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
52897-6 |
|
|
|
|
Both |
|
|
|
0 |
Platinum Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.24 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |